SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 147 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $59,000 | -59.9% | 11,956 | -2.6% | 0.02% | -82.8% |
| Q2 2021 | $147,000 | -16.9% | 12,271 | -1.7% | 0.13% | +139.3% |
| Q2 2018 | $177,000 | -62.6% | 12,486 | -49.9% | 0.06% | -51.3% |
| Q1 2018 | $473,000 | -54.3% | 24,911 | -60.5% | 0.12% | -62.0% |
| Q4 2017 | $1,034,000 | +394.7% | 63,075 | +353.8% | 0.30% | +413.6% |
| Q3 2017 | $209,000 | +65.9% | 13,900 | -2.8% | 0.06% | +34.1% |
| Q2 2017 | $126,000 | – | 14,300 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIC CAPITAL INC | 875,284 | $2,670,000 | 1.34% |
| NEXTHERA CAPITAL LP | 503,000 | $1,534,000 | 0.90% |
| Opaleye Management Inc. | 400,000 | $1,220,000 | 0.72% |
| WASATCH ADVISORS LP | 7,256,260 | $22,132,000 | 0.33% |
| Cormorant Asset Management, LP | 650,000 | $1,983,000 | 0.27% |
| Sicart Associates LLC | 101,950 | $311,000 | 0.22% |
| Baker Brothers Advisors | 4,055,876 | $12,370,000 | 0.12% |
| Leisure Capital Management | 43,008 | $131,000 | 0.12% |
| Piermont Capital Management Inc. | 165,569 | $505,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 837,963 | $2,556,000 | 0.10% |